Paige M Mortimer

884 total citations
7 papers, 335 citations indexed

About

Paige M Mortimer is a scholar working on Immunology, Infectious Diseases and Molecular Biology. According to data from OpenAlex, Paige M Mortimer has authored 7 papers receiving a total of 335 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Immunology, 4 papers in Infectious Diseases and 1 paper in Molecular Biology. Recurrent topics in Paige M Mortimer's work include COVID-19 Clinical Research Studies (3 papers), Neutrophil, Myeloperoxidase and Oxidative Mechanisms (3 papers) and SARS-CoV-2 and COVID-19 Research (2 papers). Paige M Mortimer is often cited by papers focused on COVID-19 Clinical Research Studies (3 papers), Neutrophil, Myeloperoxidase and Oxidative Mechanisms (3 papers) and SARS-CoV-2 and COVID-19 Research (2 papers). Paige M Mortimer collaborates with scholars based in United Kingdom, India and South Sudan. Paige M Mortimer's co-authors include R. Germanier, Stanley J. Cryz, Maria Prendecki, Michelle Willicombe, David Thomas, Stephen P. McAdoo, Candice Clarke, Liz Lightstone, Tina Thomson and Stacey McIntyre and has published in prestigious journals such as Nature Communications, Journal of Clinical Microbiology and Frontiers in Immunology.

In The Last Decade

Paige M Mortimer

6 papers receiving 329 citations

Peers

Paige M Mortimer

ID

MM

IMMUN

MB

EPIDE

Laura Cardeñoso Spain

Hajib N. Madhavan India

Paola Canepa Italy

Irene Hannet United States

Jenny E. Emerson United Kingdom

Akbar Kanji Pakistan

Kazuhiro Horiba Japan

Raffaella Marocco Italy

Ernesto Hinojosa United States

Zahra Zahid Piracha Pakistan

Laura Cardeñoso Spain

Paige M Mortimer

176 ×1.0

ID

18 ×0.2

MM

21 ×0.3

IMMUN

24 ×0.4

MB

256 ×4.3

EPIDE

Citations per year, relative to Paige M Mortimer Paige M Mortimer (= 1×) peers Laura Cardeñoso

Countries citing papers authored by Paige M Mortimer

Since Specialization

Citations

This map shows the geographic impact of Paige M Mortimer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paige M Mortimer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paige M Mortimer more than expected).

Fields of papers citing papers by Paige M Mortimer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paige M Mortimer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paige M Mortimer. The network helps show where Paige M Mortimer may publish in the future.

Co-authorship network of co-authors of Paige M Mortimer

This figure shows the co-authorship network connecting the top 25 collaborators of Paige M Mortimer. A scholar is included among the top collaborators of Paige M Mortimer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paige M Mortimer. Paige M Mortimer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Mortimer, Paige M, et al.. (2025). Chronic granulomatous disease: lessons in cell biology from monogenic immunodeficiency. Clinical & Experimental Immunology. 219(1).

2.

Mortimer, Paige M, Joe Thomas, Eve L. Coomber, et al.. (2023). A novel mutation in EROS (CYBC1) causes chronic granulomatous disease. Clinical Immunology. 255. 109761–109761. 5 indexed citations

3.

Martin, Paul, Sarah Gleeson, Candice Clarke, et al.. (2022). Comparison of immunogenicity and clinical effectiveness between BNT162b2 and ChAdOx1 SARS-CoV-2 vaccines in people with end-stage kidney disease receiving haemodialysis: A prospective, observational cohort study. The Lancet Regional Health - Europe. 21. 100478–100478. 6 indexed citations

4.

Buang, Norzawani B, Artemis Papadaki, Candice Clarke, et al.. (2022). Multi-omics identify falling LRRC15 as a COVID-19 severity marker and persistent pro-thrombotic signals in convalescence. Nature Communications. 13(1). 7775–7775. 19 indexed citations

5.

Prendecki, Maria, Candice Clarke, Helena Edwards, et al.. (2021). Humoral and T-cell responses to SARS-CoV-2 vaccination in patients receiving immunosuppression. Annals of the Rheumatic Diseases. 80(10). 1322–1329. 165 indexed citations

6.

Mortimer, Paige M, et al.. (2021). Beyond the Extra Respiration of Phagocytosis: NADPH Oxidase 2 in Adaptive Immunity and Inflammation. Frontiers in Immunology. 12. 733918–733918. 31 indexed citations

7.

Cryz, Stanley J., et al.. (1986). Seroepidemiology of Klebsiella bacteremic isolates and implications for vaccine development. Journal of Clinical Microbiology. 23(4). 687–690. 109 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact